Hongfei Chen1,2, Zhousheng Jin2, Fangfang Xia2, Zhijian Fu3. 1. Department of Pain Management, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, 324 Jingwu Road, 250021, Jinan, China. 2. Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, Zhejiang, China. 3. Department of Pain Management, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, 324 Jingwu Road, 250021, Jinan, China. zhijian_fu@163.com.
Abstract
BACKGROUND: Bupivacaine blocks many ion channels in the heart muscle, causing severe cardiotoxicity. Small-conductance calcium-activated potassium type 2 channels (SK2 channels) are widely distributed in the heart cells and are involved in relevant physiological functions. However, whether bupivacaine can inhibit SK2 channels is still unclear. This study investigated the effect of bupivacaine on SK2 channels. METHODS: The SK2 channel gene was transfected into human embryonic kidney 293 cells (HEK-293 cells) with Lipofectamine 2000. The whole-cell patch-clamp technique was used to examine the effect of bupivacaine on SK2 channels. The concentration-response relationship of bupivacaine for inhibiting SK2 currents (0 mV) was fitted to a Hill equation, and the half-maximal inhibitory concentration (IC50) value was determined. RESULTS: Bupivacaine inhibited the SK2 channels reversibly in a dose-dependent manner. The IC50 value of bupivacaine, ropivacaine, and lidocaine on SK2 currents was 16.5, 46.5, and 77.8µM, respectively. The degree of SK2 current inhibition by bupivacaine depended on the intracellular concentration of free calcium. CONCLUSIONS: The results of this study suggested the inhibitory effect of bupivacaine on SK2 channels. Future studies should explore the effects of SK2 on bupivacaine cardiotoxicity.
BACKGROUND: Bupivacaine blocks many ion channels in the heart muscle, causing severe cardiotoxicity. Small-conductance calcium-activated potassium type 2 channels (SK2 channels) are widely distributed in the heart cells and are involved in relevant physiological functions. However, whether bupivacaine can inhibit SK2 channels is still unclear. This study investigated the effect of bupivacaine on SK2 channels. METHODS: The SK2 channel gene was transfected into human embryonic kidney 293 cells (HEK-293 cells) with Lipofectamine 2000. The whole-cell patch-clamp technique was used to examine the effect of bupivacaine on SK2 channels. The concentration-response relationship of bupivacaine for inhibiting SK2 currents (0 mV) was fitted to a Hill equation, and the half-maximal inhibitory concentration (IC50) value was determined. RESULTS: Bupivacaine inhibited the SK2 channels reversibly in a dose-dependent manner. The IC50 value of bupivacaine, ropivacaine, and lidocaine on SK2 currents was 16.5, 46.5, and 77.8µM, respectively. The degree of SK2 current inhibition by bupivacaine depended on the intracellular concentration of free calcium. CONCLUSIONS: The results of this study suggested the inhibitory effect of bupivacaine on SK2 channels. Future studies should explore the effects of SK2 on bupivacaine cardiotoxicity.
Authors: Birgit Honrath; Lina Matschke; Tammo Meyer; Lena Magerhans; Fabiana Perocchi; Goutham K Ganjam; Hans Zischka; Cornelius Krasel; Albert Gerding; Barbara M Bakker; Moritz Bünemann; Stefan Strack; Niels Decher; Carsten Culmsee; Amalia M Dolga Journal: Cell Death Differ Date: 2017-03-10 Impact factor: 15.828
Authors: Chris T Bond; Paco S Herson; Timothy Strassmaier; Rebecca Hammond; Robert Stackman; James Maylie; John P Adelman Journal: J Neurosci Date: 2004-06-09 Impact factor: 6.167
Authors: Qian Zhang; Valeriy Timofeyev; Ling Lu; Ning Li; Anil Singapuri; Melissa K Long; Chris T Bond; John P Adelman; Nipavan Chiamvimonvat Journal: Circ Res Date: 2007-12-20 Impact factor: 17.367